Investor Relations

Boston Therapeutics, Inc. (OTCQB: BTHE)

Boston Therapeutics, headquartered in Boston-area (Lawrence, MA) is a pharmaceutical company focused on the development and commercialization of novel compounds based on complex carbohydrate chemistry to address unmet medical needs in diabetes.


Investor Relations


Stephen Spanos
Acting Chief Financial Officer
354 Merrimack Street #4
Suite 103
Lawrence, MA 01843

(1)603 935 9799
(1) 603 685 4784

stephen.spanos@bostonti.com


Stock Quote


BTHE
OTCQB: